Medical drugs

US FDA qualifies first AI tool to help speed liver disease drug development

Drug developers are increasingly adopting artificial intelligence technologies

This move represents a step in fulfilling China’s pledge to combat the flow of synthetic opioid ingredients to the US.

China curbs drug precursors to North America after US trade deal

The controlled substances include various piperidine derivatives and entire families of related compounds used in making fentanyl

The tussle for Metsera began with discussions between the company and potential acquirers in early 2024, with both Pfizer and Novo Nordisk, the maker of Wegovy and Ozempic, expressing interest.

Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid

[BENGALURU] Pfizer on Friday (Oct 31) filed a lawsuit against Metsera and Novo Nordisk, saying Metsera breached its merger agreement obligations in declaring the Danish drugmaker’s US$8.5 billion bid ...

The Pfizer-Trump agreement represents a highly personalised, transactional approach to healthcare policy that could set troubling precedents.

The Pfizer-Trump deal: A new chapter in drug pricing or political theatre?

The approach may generate headlines while leaving the structural problems of American pharmaceutical pricing unaddressed

Earlier this week, Trump linked Tylenol – the most popular brand of acetaminophen in the US – to autism and urged pregnant women to avoid the common painkiller.

HSA refutes Trump claim linking paracetamol and autism

[SINGAPORE] The Health Sciences Authority (HSA) said there is no conclusive scientific evidence linking paracetamol use during pregnancy to autism in children, refuting recent assertions made by US Pr...

US President Trump has linked the use of the painkiller paracetamol (Tylenol) during pregnancy to autism.

The US president is wrong on Tylenol

Scientists studying any link between the painkiller paracetamol and autism have reached no firm conclusions

The government’s ‘Made in China 2025’ plan to elevate manufacturing in 10 priority sectors also helped spur a flurry of investments in biotechnology.

China biotech’s stunning advance is changing the world’s drug pipeline

Chinese’s biotech advances, the scale of which is slowly coming into view, risk becoming another realm of superpower rivalry such as artificial intelligence and electric vehicles

WeightWatchers says the restructuring plan will “significantly reduce” its debt obligations.

WeightWatchers files bankruptcy as GLP-1 drugs reshape market

Prepackaged bankruptcies generally allow companies to exit Chapter 11 quickly and without disruption to their business or unsecured creditors

China’s retaliatory tariff against US imports is already taking a toll on hospitals and drugmakers.

China asks drugmakers, hospitals to find US import substitutes

The tit-for-tat escalation has seen both sides ratchet up tariffs on each other’s goods to over 100 per cent, threatening to wipe out commerce between the world’s two largest economies

Tariffs on imported finished products could be passed through to consumers by the wholesale or retail distributors paying the tariff.

US pharma tariffs would raise US drug costs by US$51 billion annually, report finds

[LONDON] A 25 per cent US tariff on pharmaceutical imports would increase US drug costs by nearly US$51 billion annually, boosting US prices by as much as 12.9 per cent if passed on, a report commissi...